An anti-irritative and anti-inflammatory topical cream for the symptomatic treatment of dermatitis and management of erythema.
|Regulatory status||EU: Medical Device Class IIA|
|Principle ingredients||Sodium Hyaluronate Butyrate Formate, a Hyaluronic Acid derivative in which hydroxyl functions of the polysaccharide are substituted by Butyric acid (Hyaluromimethic Technology)|
|Indications||Erythema and Dermatitis|
|IP||Protected by patent rights expiring in 2027.|